Allergan is recalling 111,132 cartons (each containing 10 vials) of INFed (iron dextran injection USP) 100 mg elemental iron/2 mL (50 mg/mL). The recall was issued because the medication failed stability testing, showing iron content that was outside of the required specifications. Using a medication with incorrect iron levels may result in patients receiving a dosage that is different than what was prescribed by their doctor.
The medication was found to have iron content outside of its approved specifications during stability testing. This instability could lead to ineffective treatment of iron deficiency or potential adverse reactions if the iron concentration does not meet safety standards.
Contact healthcare provider and return to pharmacy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.